ONXX Higher Ahead of Expected Survival Data on Sorafenib
Tweet Send to a Friend
Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) is ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
